৳ ০.০০
আপনার সব স্বাস্থ্যসেবার সমাধান — এখন এক জায়গাতেই
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
৳ ০.০০
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
Quantity:
Products
Payment
Delivery
Indications Afalino is indicated for the treatment of partial-onset seizures in adult patients.
Pharmacology Cenobamate is a positive GABA-A modulator and inhibits voltage-gated sodium channels. This increases the threshold for generating action potentials and decreases their frequency. Its dual mechanisms contribute to strong anti-seizure activity.
Dosage & Administration
Can be taken with or without food.
Initial dosage: Week 1–2: 12.5 mg once daily
Titration regimen:
Week 3–4: 25 mg once daily
Week 5–6: 50 mg once daily
Week 7–8: 100 mg once daily
Week 9–10: 150 mg once daily
Maintenance dosage: Week 11 onward: 200 mg once daily
Maximum dosage: May be increased by 50 mg increments every 2 weeks up to 400 mg once daily, based on clinical response and tolerability.
Interactions
Phenytoin: Gradually decrease dose up to 50%
Phenobarbital, Clobazam: Reduce dose as needed
Lamotrigine, Carbamazepine: Increase dose as needed
CYP2B6, CYP3A substrates: Increase dose as needed
CYP2C19 substrates: Reduce dose as needed
Oral contraceptives: Effectiveness may be reduced; use non-hormonal alternatives.
Contraindications
Hypersensitivity to Cenobamate or excipients
Familial Short QT syndrome
Side Effects
Common: Somnolence, fatigue, dizziness, nausea, constipation, double vision, decreased appetite, diarrhea, weakness
Rare: Severe allergic reaction
Pregnancy & Lactation
Pregnancy: May cause fetal harm; use only if benefits outweigh risks
Lactation: Unknown if present in breast milk; effects on infant not established
Precautions & Warnings
Risk of multiorgan hypersensitivity (DRESS), QT shortening, suicidal thoughts
Monitor somnolence, fatigue; advise against driving/machinery use until stable
Gradual withdrawal recommended to avoid increased seizure frequency
Use caution with other CNS depressants or alcohol
Use in Special Populations
Pediatrics: Not established (<18 years)
Geriatrics: Start at low dose
Renal impairment: Max 300 mg/day; avoid in end-stage renal disease or dialysis
Hepatic impairment: Use with caution in mild/moderate cases; avoid in severe impairment
Overdose Effects Discontinue Afalino and provide supportive care until toxicity resolves.
Therapeutic Class Adjunct anti-epileptic drug






Cenobamate is an antiepileptic (anticonvulsant) medicine used to treat partial-onset (focal) seizures in adults. It works through a dual mechanism: enhancing inhibitory GABA activity and reducing excitatory sodium channel activity in the brain, helping to stabilize abnormal electrical activity.
Cenobamate is used in epilepsy patients to reduce seizure frequency and severity, especially in treatment-resistant cases. It helps improve seizure control and overall quality of life in people with chronic epilepsy.

